Skip to main content
AkademIndex

Products

For developers

AkademBaseOpen API for the ecosystem
← Back to work

Works cited by this work

120 works

Work: Aptasensors in colorectal Cancer: Emerging tools for precision diagnostics

  1. Targeting the proliferation of glioblastoma cells and enhancement of doxorubicin and temozolomide cytotoxicity through inhibition of PFKFB4 and HMOX1 genes with siRNAs

    Hamzeh J. Al‐Ameer, Malek Zihlif, Ahmed O. Maslat +13

    Article202510 citations
    ABI

  2. <scp>CHB</scp> patients with <scp>rtA181T</scp>‐mutated <scp>HBV</scp> infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes

    Qiqi Ning, Tongwang Yang, Xianghua Guo +8

    Article20238 citations
    ABI

  3. The Efficacy of Decision Aids on Enhancing Early Cancer Screening: A Meta‐Analysis of Randomized Controlled Trials

    Yang Chen, Linna Li, Xiaoli Chen +2

    Review article20255 citations
    ABI

  4. Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer

    Thomas Reinert, Tenna Vesterman Henriksen, Emil Christensen +35

    Article20194 citations
    ABI

  5. Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application

    Tatsuo Adachi, Yoshikazu Nakamura

    Review article20193 citations
    ABI

  6. Advances in aptamer-based electrochemical biosensors for disease diagnosis: integration of DNA and nanomaterials

    SaRi GeGen, Gedong Meng, Gerile Aodeng +2

    Article20253 citations
    ABI

  7. Aptamers: Cutting edge of cancer therapies

    Sarah Shigdar, Brett Schrand, Paloma H. Giangrande +1

    Review article20212 citations
    ABI

  8. Biomarkers in Colorectal Cancer: The Role of Translational Proteomics Research

    Bruno Augusto Alves Martins, Gabriel Fonseca de Bulhões, Igor Norat Cavalcanti +3

    Review article20192 citations
    ABI

  9. HER2 in Colorectal Cancer: The Long and Winding Road From Negative Predictive Factor to Positive Actionable Target

    Selma Ahcene Djaballah, Francesca Daniel, A. Milani +2

    Article20222 citations
    ABI

  10. SEPA: signaling entropy-based algorithm to evaluate personalized pathway activation for survival analysis on pan-cancer data

    Xingyi Li, Min Li, Ju Xiang +2

    Article20222 citations
    ABI

  11. <i>CCAT2</i>, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer

    Hui Ling, Riccardo Spizzo, Yaser Atlasi +50

    Article20132 citations
    ABI

  12. Blood-derived lncRNAs as biomarkers for cancer diagnosis: the Good, the Bad and the Beauty

    Cédric Badowski, Bing He, Lana X. Garmire

    Review article20222 citations
    ABI

  13. Ultrasensitive FRET-based aptasensor for interleukin-6 as a biomarker for COVID-19 progression using nitrogen-doped carbon quantum dots and gold nanoparticles

    Mohamad Mahani, Majedeh Faghihi-Fard, Faten Divsar +2

    Article20222 citations
    ABI

  14. Activatable fluorescent probes for imaging and diagnosis of hepatocellular carcinoma

    Xiaoxiao Men, Fanghong Liu, Mingyue Gong +5

    Article20242 citations
    ABI

  15. TRPC1 and TRPC5 in Colorectal Cancer: Mechanisms, Prognostic Markers, and Therapeutic Targets

    Manal A. Abbas, Aya Y. Al‐Kabariti, Randa El‐Rayyes +2

    Review article20252 citations
    ABI

  16. Untitled

    Other1 citations
    ABI

  17. Untitled

    Other1 citations
    ABI

  18. Untitled

    Other1 citations
    ABI

  19. Untitled

    Other1 citations
    ABI

  20. Untitled

    Other1 citations
    ABI

  21. Untitled

    Other1 citations
    ABI

  22. Untitled

    Other1 citations
    ABI

  23. Untitled

    Other1 citations
    ABI

  24. Untitled

    Other1 citations
    ABI

  25. Untitled

    Other1 citations
    ABI